Erez Vigodman
2017
In 2017, Erez Vigodman earned a total compensation of $2.8M as Former President and CEO at Teva Pharmaceutical Industries, a 56% decrease compared to previous year.
Compensation breakdown
| Salary | $1,378,702 |
|---|---|
| Other | $1,455,704 |
| Total | $2,834,406 |
Vigodman received $1.5M in other compensation, accounting for 51% of the total pay in 2017.
Vigodman also received $1.4M in salary.
Rankings
In 2017, Erez Vigodman's compensation ranked 3,855th out of 14,666 executives tracked by ExecPay. In other words, Vigodman earned more than 73.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,855 out of 14,666 | 74th |
Division Manufacturing | 1,348 out of 5,770 | 77th |
Major group Chemicals And Allied Products | 382 out of 2,074 | 82nd |
Industry group Drugs | 296 out of 1,730 | 83rd |
Industry Pharmaceutical Preparations | 236 out of 1,329 | 82nd |
Source: SEC filing on April 25, 2018.
Vigodman's colleagues
We found nine more compensation records of executives who worked with Erez Vigodman at Teva Pharmaceutical Industries in 2017.
2017
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Yitzhak Peterburg
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Rob Koremans
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2017
Michael Hayden
Teva Pharmaceutical Industries
Chief Scientific Officer
2017
Eyal Desheh
Teva Pharmaceutical Industries
Chief Financial Officer
2017
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2017
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, Global Human Resources
2017
Michael McClellan
Teva Pharmaceutical Industries